[1] Donath, M.Y. and Shoelson, S.E.:Type 2 diabetes as an inflammatory disease. Nature Reviews. Immunology. 11: 98-107.(2011).
[2] Yabe, D., Seino, Y., Fukushima, M. and Seino, S.:Beta cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in east asians. Current Diabetes Reports. 15: 602.(2015).
[3] Li, Y., He, Y., Qi, L., Jaddoe, V.W., Feskens, E.J., Yang, X., Ma, G. and Hu, F.B.:Exposure to the chinese famine in early life and the risk of hyperglycemia and type 2 diabetes in adulthood. Diabetes. 59: 2400-2406.(2010).
[4] Ekamper, P., van Poppel, F., Stein, A.D., Bijwaard, G.E. and Lumey, L.H.:Prenatal famine exposure and adult mortality from cancer, cardiovascular disease, and other causes through age 63 years. American Journal of Epidemiology. 181: 271-279.(2015).
[5] Gluckman, P.D., Seng, C.Y., Fukuoka, H., Beedle, A.S. and Hanson, M.A.:Low birthweight and subsequent obesity in Japan. Lancet. 369: 1081-1082.(2007).
[6] Suzuki, K., Nomura, K., Takenoshita, S., Ando, K. and Kido, M.:Combination of parity and pre-pregnancy bmi and low birth weight infants among Japanese women of reproductive age. Industrial Health. 54: 515-520.(2016).
[7] 厚生労働省, 平成 30 年人口動態統計月報年計（概数）の概況, 平成 30 年.
[8] 日本産科婦人科学会 ART データブック JSOG, 2018 年版.
[9] de Rooij, S.R., Painter, R.C., Phillips, D.I., Osmond, C., Michels, R.P., Godsland, I.F., Bossuyt, P.M., Bleker, O.P. and Roseboom, T.J.:Impaired insulin secretion after prenatal exposure to the dutch famine. Diabetes Care. 29: 1897-1901.(2006).
[10] de Boo, H.A. and Harding, J.E.:The developmental origins of adult disease (barker) hypothesis. The Australian & New Zealand Journal of Obstetrics & Gynaecology. 46: 4-14.(2006).
[11] Qin, J.B., Sheng, X.Q., Wu, D., Gao, S.Y., You, Y.P., Yang, T.B. and Wang, H.:Worldwide prevalence of adverse pregnancy outcomes among singleton pregnancies after in vitro fertilization/intracytoplasmic sperm injection: A systematic review and meta-analysis. Archives of Gynecology and Obstetrics. 295: 285-301.(2017).
[12] Chen, M., Norman, R.J. and Heilbronn, L.K.:Does in vitro fertilisation increase type 2 diabetes and cardiovascular risk? Current Diabetes Reviews. 7: 426-432.(2011).
[13] Garofano, A., Czernichow, P. and Breant, B.:Beta-cell mass and proliferation following late fetal and early postnatal malnutrition in the rat. Diabetologia. 41: 1114-1120.(1998).
[14] Simmons, R.A., Templeton, L.J. and Gertz, S.J.:Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes. 50: 2279-2286.(2001).
[15] Scott, K.A., Yamazaki, Y., Yamamoto, M., Lin, Y., Melhorn, S.J., Krause, E.G., Woods, S.C., Yanagimachi, R., Sakai, R.R. and Tamashiro, K.L.:Glucose parameters are altered in mouse offspring produced by assisted reproductive technologies and somatic cell nuclear transfer. Biology of Reproduction. 83: 220-227.(2010).
[16] Jansen, S., Esmaeilpour, T., Pantaleon, M. and Kaye, P.L.:Glucose affects monocarboxylate cotransporter (mct) 1 expression during mouse preimplantation development. Reproduction. 131: 469-479.(2006).
[17] Pantaleon, M., Scott, J. and Kaye, P.L.:Nutrient sensing by the early mouse embryo:Hexosamine biosynthesis and glucose signaling during preimplantation development. Biology of Reproduction. 78: 595-600.(2008).
[18] Watkins, A.J., Ursell, E., Panton, R., Papenbrock, T., Hollis, L., Cunningham, C., Wilkins, A., Perry, V.H., Sheth, B., Kwong, W.Y., Eckert, J.J., Wild, A.E., Hanson, M.A., Osmond, C. and Fleming, T.P.:Adaptive responses by mouse early embryos to maternal diet protect fetal growth but predispose to adult onset disease. Biology of Reproduction. 78: 299-306.(2008).
[19] University of yamanashi. S. Kishigami, k. Mochizuki, t. Wakayama. The method for producing diabetic animal model and the diabetic animal model. Patent. P2020-31551a. 2020-03-05. (Japanese).
[20] Fukushima, M., Suzuki, H. and Seino, Y.:Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Research and Clinical Practice. 66 Suppl 1: S37-43.(2004).
[21] Tominaga, M., Eguchi, H., Manaka, H., Igarashi, K., Kato, T. and Sekikawa, A.:Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The funagata diabetes study. Diabetes Care. 22: 920- 924.(1999).
[22] Niedowicz, D.M. and Daleke, D.L.:The role of oxidative stress in diabetic complications. Cell Biochemistry and Biophysics. 43: 289-330.(2005).
[23] Domingueti, C.P., Dusse, L.M., Carvalho, M., de Sousa, L.P., Gomes, K.B. and Fernandes, A.P.:Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. Journal of Diabetes and its Complications. 30: 738-745.(2016).
[24] Pober, J.S.:Endothelial activation: Intracellular signaling pathways. Arthritis Research. 4 Suppl 3: S109-116.(2002).
[25] Majewska, E., Paleolog, E., Baj, Z., Kralisz, U., Feldmann, M. and Tchorzewski, H.:Role of tyrosine kinase enzymes in tnf-alpha and il-1 induced expression of icam-1 and vcam-1 on human umbilical vein endothelial cells. Scandinavian Journal of Immunology. 45: 385-392.(1997).
[26] Galkina, E. and Ley, K.:Immune and inflammatory mechanisms of atherosclerosis (*). Annual Review of Immunology. 27: 165-197.(2009).
[27] Pickup, J.C., Chusney, G.D., Thomas, S.M. and Burt, D.:Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sciences. 67: 291-300.(2000).
[28] Imai, C., Saito, M., Mochizuki, K., Fuchigami, M., Goda, T. and Osonoi, T.:Cotreatment with the alpha-glucosidase inhibitor miglitol and dpp-4 inhibitor sitagliptin improves glycemic control and reduces the expressions of cvd risk factors in type 2 diabetic Japanese patients. Metabolism: Clinical and Experimental. 63: 746- 753.(2014).
[29] Futosi, K., Fodor, S. and Mocsai, A.:Neutrophil cell surface receptors and their intracellular signal transduction pathways. International Immunopharmacology. 17: 638-650.(2013).
[30] Bouma, G., Lam-Tse, W.K., Wierenga-Wolf, A.F., Drexhage, H.A. and Versnel, M.A.:Increased serum levels of mrp-8/14 in type 1 diabetes induce an increased expression of cd11b and an enhanced adhesion of circulating monocytes to fibronectin. Diabetes. 53: 1979-1986.(2004).
[31] Foell, D., Wittkowski, H., Kessel, C., Luken, A., Weinhage, T., Varga, G., Vogl, T., Wirth, T., Viemann, D., Bjork, P., van Zoelen, M.A., Gohar, F., Srikrishna, G., Kraft, M. and Roth, J.:Proinflammatory s100a12 can activate human monocytes via toll-like receptor 4. American Journal of Respiratory and Critical Care Medicine. 187: 1324- 1334.(2013).
[32] Bril, F. and Cusi, K.:Nonalcoholic fatty liver disease: The new complication of type 2 diabetes mellitus. Endocrinology and Metabolism Clinics of North America. 45: 765- 781.(2016).
[33] Younossi, Z.M., Golabi, P., de Avila, L., Paik, J.M., Srishord, M., Fukui, N., Qiu, Y., Burns, L., Afendy, A. and Nader, F.:The global epidemiology of nafld and nash in patients with type 2 diabetes: A systematic review and meta-analysis. Journal of Hepatology. 71: 793-801.(2019).
[34] Matteoni, C.A., Younossi, Z.M., Gramlich, T., Boparai, N., Liu, Y.C. and McCullough, A.J.:Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology. 116: 1413-1419.(1999).
[35] White, D.L., Kanwal, F. and El-Serag, H.B.:Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association. 10: 1342-1359 e1342.(2012).
[36] Bellentani, S.:The epidemiology of non-alcoholic fatty liver disease. Liver International : Official Journal of the International Association for the Study of the Liver. 37 Suppl 1: 81-84.(2017).
[37] Bessone, F., Razori, M.V. and Roma, M.G.:Molecular pathways of nonalcoholic fatty liver disease development and progression. Cellular and Molecular Life Sciences : CMLS. 76: 99-128.(2019).
[38] Brunt, E.M.:Grading and staging the histopathological lesions of chronic hepatitis: The knodell histology activity index and beyond. Hepatology. 31: 241-246.(2000).
[39] Dulai, P.S., Singh, S., Patel, J., Soni, M., Prokop, L.J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., Stal, P., Wong, V.W., Kechagias, S., Hultcrantz, R. and Loomba, R.:Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis. Hepatology. 65: 1557-1565.(2017).
[40] Kasumov, T., Li, L., Li, M., Gulshan, K., Kirwan, J.P., Liu, X., Previs, S., Willard, B., Smith, J.D. and McCullough, A.:Ceramide as a mediator of non-alcoholic fatty liver disease and associated atherosclerosis. PloS One. 10: e0126910.(2015).
[41] Hirsova, P., Ibrabim, S.H., Gores, G.J. and Malhi, H.:Lipotoxic lethal and sublethal stress signaling in hepatocytes: Relevance to nash pathogenesis. Journal of Lipid Research. 57: 1758-1770.(2016).
[42] Schleicher, E. and Nerlich, A.:The role of hyperglycemia in the development of diabetic complications. Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et Metabolisme. 28: 367-373.(1996).
[43] Anders, H.J., Huber, T.B., Isermann, B. and Schiffer, M.:Ckd in diabetes: Diabet ic kidney disease versus nondiabetic kidney disease. Nature Reviews. Nephrology. 14:361-377.(2018).
[44] Tervaert, T.W., Mooyaart, A.L., Amann, K., Cohen, A.H., Cook, H.T., Drachenberg, C.B., Ferrario, F., Fogo, A.B., Haas, M., de Heer, E., Joh, K., Noel, L.H., Radhakrishnan, J., Seshan, S.V., Bajema, I.M. and Bruijn, J.A.:Pathologic classification of diabetic nephropathy. Journal of the American Society of Nephrology : JASN. 21: 556- 563.(2010).
[45] Fu, H., Liu, S., Bastacky, S.I., Wang, X., Tian, X.J. and Zhou, D.:Diabetic kidney diseases revisited: A new perspective for a new era. Molecular Metabolism. 30: 250- 263.(2019).
[46] Asare, E.K., Jaiswal, S., Maley, J., Baga, M., Sammynaiken, R., Rossnagel, B.G. and Chibbar, R.N.:Barley grain constituents, starch composition, and structure affect starch in vitro enzymatic hydrolysis. Journal of Agricultural and Food Chemistry. 59: 4743- 4754.(2011).
[47] Bai, Y.P., Zhou, H.M., Zhu, K.R. and Li, Q.:Effect of thermal treatment on the physicochemical, ultrastructural and nutritional characteristics of whole grain highland barley. Food Chemistry. 346: 128657.(2021).
[48] Matsuoka, T., Tsuchida, A., Yamaji, A., Kurosawa, C., Shinohara, M., Takayama, I., Nakagomi, H., Izumi, K., Ichikawa, Y., Hariya, N., Yamashita, S. and Mochizuki, K.:Consumption of a meal containing refined barley flour bread is associated with a lower postprandial blood glucose concentration after a second meal compared with one containing refined wheat flour bread in healthy Japanese: A randomized control trial. Nutrition. 72: 110637.(2020).
[49] Arcidiacono, M.V., Carrillo-Lopez, N., Panizo, S., Castro-Grattoni, A.L., Valcheva, P., Ulloa, C., Rodriguez-Carrio, J., Cardus, A., Quiros-Caso, C., Martinez-Arias, L., Martinez-Salgado, C., Motilva, M.J., Rodriguez-Suarez, C., Cannata-Andia, J.B. and Dusso, A.S.:Barley-ss-glucans reduce systemic inflammation, renal injury and aortic calcification through adam17 and neutral-sphingomyelinase2 inhibition. Scientific Reports. 9: 17810.(2019).
[50] Tsuchiya, S., Yasui, M. and Ohashi, K.:Assessing body dissatisfaction in Japanese women during the second trimester of pregnancy using a new figure rating scale. Nursing & Health Sciences. 21: 367-374.(2019).
[51] Fukuoka, H.:[environmental effect in utero for adult disease]. Nihon Eiseigaku Zasshi. Japanese Journal of Hygiene. 71: 37-40.(2016).
[52] Ducati, A., Fava, E. and Motti, E.D.:Neuronal generators of the visual evoked potentials: Intracerebral recording in awake humans. Electroencephalography and Clinical Neurophysiology. 71: 89-99.(1988).
[53] Zhang, Y., Ying, Y., Zhou, L., Fu, J., Shen, Y. and Ke, C.:Exposure to chinese famine in early life modifies the association between hyperglycaemia and cardiovascular disease. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD. 29: 1230- 1236.(2019).
[54] Tian, J., Qiu, M., Li, Y., Zhang, X., Wang, H., Sun, S., Sharp, N.S., Tong, W., Zeng, H., Zheng, S., Song, X., Wang, W. and Ning, G.:Contribution of birth weight and adult waist circumference to cardiovascular disease risk in a longitudinal study. Scientific Reports. 7: 9768.(2017).
[55] Zhao, H., Song, A., Zhang, Y., Zhen, Y., Song, G. and Ma, H.:The association between birth weight and the risk of type 2 diabetes mellitus: A systematic review and meta - analysis. Endocrine Journal. 65: 923-933.(2018).
[56] Forstermann, U.:Nitric oxide and oxidative stress in vascular disease. Pflugers Archiv : European Journal of Physiology. 459: 923-939.(2010).
[57] Yan, L.J.:Pathogenesis of chronic hyperglycemia: From reductive stress to oxidative stress. Journal of Diabetes Research. 2014: 137919.(2014).
[58] Tanaka, Y., Mochizuki, K., Fukaya, N., Shimada, M. and Goda, T.:The alpha- glucosidase inhibitor miglitol suppresses postprandial hyperglycaemia and interleukin- 1beta and tumour necrosis factor-alpha gene expression in rat peripheral leucocytes induced by intermittent sucrose loading. The British Journal of Nutrition. 102: 221- 225.(2009).
[59] Osonoi, T., Saito, M., Mochizuki, K., Fukaya, N., Muramatsu, T., Inoue, S., Fuchigami, M. and Goda, T.:The alpha-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus. Metabolism: Clinical and Experimental. 59: 1816-1822.(2010).
[60] Fukaya, N., Mochizuki, K., Shimada, M. and Goda, T.:The alpha-glucosidase inhibitor miglitol decreases glucose fluctuations and gene expression of inflammator y cytokines induced by hyperglycemia in peripheral leukocytes. Nutrition. 25: 657-667.(2009).
[61] Livak, K.J. and Schmittgen, T.D.:Analysis of relative gene expression data using real - time quantitative pcr and the 2(-delta delta c(t)) method. Methods. 25: 402-408.(2001).
[62] Deodati, A., Argemi, J., Germani, D., Puglianiello, A., Alisi, A., De Stefanis, C., Ferrero, R., Nobili, V., Aragon, T. and Cianfarani, S.:The exposure to uteroplacental insufficiency is associated with activation of unfolded protein response in postnatal life. PloS One. 13: e0198490.(2018).
[63] Jin, F., Honma, K., Mochizuki, K. and Goda, T.:Undernutrition in pregnant rats induces glucose intolerance with enhanced expression of inflammation-related genes in peripheral leukocytes of the offspring. Journal of Nutritional Science and Vitaminology. 65: 534-540.(2019).
[64] Schittenhelm, L., Hilkens, C.M. and Morrison, V.L.:Beta2 integrins as regulators of dendritic cell, monocyte, and macrophage function. Frontiers in Immunology. 8: 1866.(2017).
[65] Hazuda, D.J., Strickler, J., Kueppers, F., Simon, P.L. and Young, P.R.:Processing of precursor interleukin 1 beta and inflammatory disease. The Journal of Biological Chemistry. 265: 6318-6322.(1990).
[66] Zelova, H. and Hosek, J.:Tnf-alpha signalling and inflammation: Interactions between old acquaintances. Inflammation Research : Official Journal of the European Histamine Research Society ... [et al.]. 62: 641-651.(2013).
[67] Wang, S., Song, R., Wang, Z., Jing, Z. and Ma, J.:S100a8/a9 in inflammation. Frontiers in Immunology. 9: 1298.(2018).
[68] Leclerc, E., Fritz, G., Weibel, M., Heizmann, C.W. and Galichet, A.:S100b and s100a6 differentially modulate cell survival by interacting with distinct rage (receptor for advanced glycation end products) immunoglobulin domains. The Journal of Biological Chemistry. 282: 31317-31331.(2007).
[69] Laakso, M.:Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes. 48: 937-942.(1999).
[70] Bonora, E. and Muggeo, M.:Postprandial blood glucose as a risk factor for cardiovascular disease in type ii diabetes: The epidemiological evidence. Diabetologia. 44: 2107-2114.(2001).
[71] Ridker, P.M., Everett, B.M., Thuren, T., MacFadyen, J.G., Chang, W.H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S.D., Kastelein, J.J.P., Cornel, J.H., Pais, P., Pella, D., Genest, J., Cifkova, R., Lorenzatti, A., Forster, T., Kobalava, Z., Vida - Simiti, L., Flather, M., Shimokawa, H., Ogawa, H., Dellborg, M., Rossi, P.R.F., Troquay, R.P.T., Libby, P. and Glynn, R.J.:Antiinflammatory therapy with canakinumab for atherosclerotic disease. The New England Journal of Medicine. 377: 1119-1131.(2017).
[72] Paravicini, T.M. and Touyz, R.M.:Nadph oxidases, reactive oxygen species, and hypertension: Clinical implications and therapeutic possibilities. Diabetes Care. 31 Suppl 2: S170-180.(2008).
[73] Elnakish, M.T., Hassanain, H.H., Janssen, P.M., Angelos, M.G. and Khan, M.:Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: Important role of rac/nadph oxidase. The Journal of Pathology. 231: 290-300.(2013).
[74] Gao, X., Zhang, H., Schmidt, A.M. and Zhang, C.:Age/rage produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice. American Journal of Physiology. Heart and Circulatory Physiology. 295: H491-498.(2008).
[75] Adaikalakoteswari, A., Balasubramanyam, M., Rema, M. and Mohan, V.:Differential gene expression of nadph oxidase (p22phox) and hemoxygenase-1 in patients with type 2 diabetes and microangiopathy. Diabetic Medicine : A Journal of the British Diabetic Association. 23: 666-674.(2006).
[76] Genuth, S.M., Przybylski, R.J. and Rosenberg, D.M.:Insulin resistance in genetically obese, hyperglycemic mice. Endocrinology. 88: 1230-1238.(1971).
[77] Dubuc, P.U.:Effects of limited food intake on the obese-hyperglycemic syndrome. The American Journal of Physiology. 230: 1474-1479.(1976).
[78] Cohen, M.M., Jr.:Perspectives on rage signaling and its role in cardiovascular disease. American Journal of Medical Genetics. Part A. 161A: 2750-2755.(2013).
[79] Trevelin, S.C., Shah, A.M. and Lombardi, G.:Beyond bacterial killing: Nadph oxidase 2 is an immunomodulator. Immunology Letters. 221: 39-48.(2020).
[80] Li, H., Luo, Y.F., Wang, Y.S., Yang, Q., Xiao, Y.L., Cai, H.R. and Xie, C.M.:Using ros as a second messenger, nadph oxidase 2 mediates macrophage senescence via interaction with nf-kappab during pseudomonas aeruginosa infection. Oxidative Medicine and Cellular Longevity. 2018: 9741838.(2018).
[81] Kovatcheva-Datchary, P., Nilsson, A., Akrami, R., Lee, Y.S., De Vadder, F., Arora, T., Hallen, A., Martens, E., Bjorck, I. and Backhed, F.:Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of prevotella. Cell Metabolism. 22: 971-982.(2015).
[82] Miyamoto, J., Watanabe, K., Taira, S., Kasubuchi, M., Li, X., Irie, J., Itoh, H. and Kimura, I.:Barley beta-glucan improves metabolic condition via short-chain fatty acids produced by gut microbial fermentation in high fat diet fed mice. PloS One. 13:e0196579.(2018).
[83] Fujimoto, S., Mochizuki, K., Shimada, M., Murayama, Y. and Goda, T.:Variation in gene expression of inflammatory cytokines in leukocyte-derived cells of high-fat-diet- induced insulin-resistant rats. Bioscience, Biotechnology, and Biochemistry. 72: 2572- 2579.(2008).
[84] Fuse, Y., Higa, M., Miyashita, N., Fujitani, A., Yamashita, K., Ichijo, T., Aoe, S. and Hirose, T.:Effect of high beta-glucan barley on postprandial blood glucose and insulin levels in type 2 diabetic patients. Clinical Nutrition Research. 9: 43-51.(2020).
[85] Murayama, Y., Mochizuki, K., Shimada, M., Fujimoto, S., Nukui, K., Shibata, K. and Goda, T.:Dietary supplementation with alpha-amylase inhibitor wheat albumin to high- fat diet-induced insulin-resistant rats is associated with increased expression of genes related to fatty acid synthesis in adipose tissue. Journal of Agricultural and Food Chemistry. 57: 9332-9338.(2009).
[86] Younossi, Z., Tacke, F., Arrese, M., Chander Sharma, B., Mostafa, I., Bugianesi, E., Wai-Sun Wong, V., Yilmaz, Y., George, J., Fan, J. and Vos, M.B.:Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 69: 2672-2682.(2019).
[87] Anstee, Q.M., Targher, G. and Day, C.P.:Progression of nafld to diabetes mellitus, cardiovascular disease or cirrhosis. Nature Reviews. Gastroenterology & Hepatology. 10: 330-344.(2013).
[88] Sandboge, S., Perala, M.M., Salonen, M.K., Blomstedt, P.A., Osmond, C., Kajantie, E., Barker, D.J. and Eriksson, J.G.:Early growth and non-alcoholic fatty liver disease in adulthood-the nafld liver fat score and equation applied on the helsinki birth cohort study. Annals of Medicine. 45: 430-437.(2013).
[89] Bugianesi, E., Bizzarri, C., Rosso, C., Mosca, A., Panera, N., Veraldi, S., Dotta, A., Giannone, G., Raponi, M., Cappa, M., Alisi, A. and Nobili, V.:Low birthweight increases the likelihood of severe steatosis in pediatric non-alcoholic fatty liver disease. The American Journal of Gastroenterology. 112: 1277-1286.(2017).
[90] Urmi, J.F., Itoh, H., Muramatsu-Kato, K., Kohmura-Kobayashi, Y., Hariya, N., Jain, D., Tamura, N., Uchida, T., Suzuki, K., Ogawa, Y., Shiraki, N., Mochizuki, K., Kubota, T. and Kanayama, N.:Plasticity of histone modifications around cidea and cidec genes with secondary bile in the amelioration of developmentally-programmed hepatic steatosis. Scientific Reports. 9: 17100.(2019).
[91] Itoh, H., Muramatsu-Kato, K., Ferdous, U.J., Kohmura-Kobayashi, Y. and Kanayama, N.:Undernourishment in utero and hepatic steatosis in later life: A potential issue in Japanese people. Congenital Anomalies. 57: 178-183.(2017).
[92] Choi, G.Y., Tosh, D.N., Garg, A., Mansano, R., Ross, M.G. and Desai, M.:Gender- specific programmed hepatic lipid dysregulation in intrauterine growth-restricted offspring. American Journal of Obstetrics and Gynecology. 196: 477 e471-477.(2007).
[93] Yamada, M., Wolfe, D., Han, G., French, S.W., Ross, M.G. and Desai, M.:Early onset of fatty liver in growth-restricted rat fetuses and newborns. Congenital Anomalies. 51: 167-173.(2011).
[94] Muramatsu-Kato, K., Itoh, H., Kohmura-Kobayashi, Y., Ferdous, U.J., Tamura, N., Yaguchi, C., Uchida, T., Suzuki, K., Hashimoto, K., Suganami, T., Ogawa, Y. and Kanayama, N.:Undernourishment in utero primes hepatic steatosis in adult mice offspring on an obesogenic diet; involvement of endoplasmic reticulum stress. Scientific Reports. 5: 16867.(2015).
[95] Ishiyama, S., Kimura, M., Umihira, N., Matsumoto, S., Takahashi, A., Nakagawa, T., Wakayama, T., Kishigami, S. and Mochizuki, K.:Mice derived from in vitro alphamem- cultured preimplantation embryos exhibit postprandial hyperglycemia and higher inflammatory gene expression in peripheral leukocytes. Bioscience, Biotechnology, and Biochemistry. 85: 1215-1226.(2021).
[96] van der Windt, D.J., Sud, V., Zhang, H., Varley, P.R., Goswami, J., Yazdani, H.O., Tohme, S., Loughran, P., O'Doherty, R.M., Minervini, M.I., Huang, H., Simmons, R.L. and Tsung, A.:Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis. Hepatology. 68: 1347- 1360.(2018).
[97] Krenkel, O., Puengel, T., Govaere, O., Abdallah, A.T., Mossanen, J.C., Kohlhepp, M., Liepelt, A., Lefebvre, E., Luedde, T., Hellerbrand, C., Weiskirchen, R., Longerich, T., Costa, I.G., Anstee, Q.M., Trautwein, C. and Tacke, F.:Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis. Hepatology. 67: 1270-1283.(2018).
[98] Liu, W., Baker, R.D., Bhatia, T., Zhu, L. and Baker, S.S.:Pathogenesis of nonalcoholic steatohepatitis. Cellular and Molecular Life Sciences : CMLS. 73: 1969-1987.(2016).
[99] Borai, I.H., Shaker, Y., Kamal, M.M., Ezzat, W.M., Ashour, E., Afify, M., Gouda, W. and Elbrashy, M.M.:Evaluation of biomarkers in egyptian patients with different grades of nonalcoholic fatty liver disease. Journal of Clinical and Translational Hepatology. 5: 109-118.(2017).
[100] Lieber, C.S., Leo, M.A., Mak, K.M., Xu, Y., Cao, Q., Ren, C., Ponomarenko, A. and DeCarli, L.M.:Acarbose attenuates experimental non-alcoholic steatohepatitis. Biochemical and Biophysical Research Communications. 315: 699-703.(2004).
[101] Yamagishi, S., Nakamura, K. and Inoue, H.:Acarbose is a promising therapeutic strategy for the treatment of patients with nonalcoholic steatohepatitis ( NASH). Medical Hypotheses. 65: 377-379.(2005).
[102] Al-Shali, R.A. and Ramadan, W.S.:Germinated barley downregulates hepatic stearoyl- coa desaturase-1 enzyme gene expression in a hepatic steatohepatitis rat model. Anatomical Science International. 95: 489-497.(2020).
[103] Chomczynski, P. and Sacchi, N.:Single-step method of rna isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry. 162: 156-159.(1987).
[104] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J.:Protein measurement with the folin phenol reagent. The Journal of Biological Chemistry. 193: 265- 275.(1951).
[105] Wang, L.Y., Le, F., Wang, N., Li, L., Liu, X.Z., Zheng, Y.M., Lou, H.Y., Xu, X.R., Chen, Y.L., Zhu, X.M., Huang, H.F. and Jin, F.:Alteration of fatty acid metabolism in the liver, adipose tissue, and testis of male mice conceived through assisted reproductive technologies: Fatty acid metabolism in art mice. Lipids in Health and Disease. 12: 5.(2013).
[106] Kanzler, S., Lohse, A.W., Keil, A., Henninger, J., Dienes, H.P., Schirmacher, P., Rose- John, S., zum Buschenfelde, K.H. and Blessing, M.:Tgf-beta1 in liver fibrosis: An inducible transgenic mouse model to study liver fibrogenesis. The American Journal of Physiology. 276: G1059-1068.(1999).
[107] Cayon, A., Crespo, J., Mayorga, M., Guerra, A. and Pons-Romero, F.:Increased expression of ob-rb and its relationship with the overexpression of tgf-beta1 and the stage of fibrosis in patients with nonalcoholic steatohepatitis. Liver International : Official Journal of the International Association for the Study of the Liver. 26: 1065- 1071.(2006).
[108] Tomita, K., Oike, Y., Teratani, T., Taguchi, T., Noguchi, M., Suzuki, T., Mizutani, A., Yokoyama, H., Irie, R., Sumimoto, H., Takayanagi, A., Miyashita, K., Akao, M., Tabata, M., Tamiya, G., Ohkura, T. and Hibi, T.:Hepatic adipor2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. Hepatology. 48: 458- 473.(2008).
[109] Chan, E.C., Jiang, F., Peshavariya, H.M. and Dusting, G.J.:Regulation of cell proliferation by nadph oxidase-mediated signaling: Potential roles in tissue repair, regenerative medicine and tissue engineering. Pharmacology & Therapeutics. 122: 97- 108.(2009).
[110] Arthur, M.J.:Fibrogenesis ii. Metalloproteinases and their inhibitors in liver fibrosis. American Journal of Physiology. Gastrointestinal and Liver Physiology. 279: G245- 249.(2000).
[111] Farrell, G.C., Mridha, A.R., Yeh, M.M., Arsov, T., Van Rooyen, D.M., Brooling, J., Nguyen, T., Heydet, D., Delghingaro-Augusto, V., Nolan, C.J., Shackel, N.A., McLennan, S.V., Teoh, N.C. and Larter, C.Z.:Strain dependence of diet-induced nash and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype. Liver International : Official Journal of the International Association for the Study of the Liver. 34: 1084-1093.(2014).
[112] Hayashi, H. and Sakai, T.:Biological significance of local tgf-beta activation in liver diseases. Frontiers in Physiology. 3: 12.(2012).
[113] Robert, S., Gicquel, T., Bodin, A., Lagente, V. and Boichot, E.:Characterization of the mmp/timp imbalance and collagen production induced by il -1beta or tnf-alpha release from human hepatic stellate cells. PloS One. 11: e0153118.(2016).
[114] Mashek, D.G.:Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in nafld. Molecular Metabolism. 50: 101115.(2021).
[115] Dropmann, A., Dediulia, T., Breitkopf-Heinlein, K., Korhonen, H., Janicot, M., Weber, S.N., Thomas, M., Piiper, A., Bertran, E., Fabregat, I., Abshagen, K., Hess, J., Angel, P., Coulouarn, C., Dooley, S. and Meindl-Beinker, N.M.:Tgf-beta1 and tgf-beta2 abundance in liver diseases of mice and men. Oncotarget. 7: 19499-19518.(2016).
[116] Demirci, G., Nashan, B. and Pichlmayr, R.:Fibrosis in chronic rejection of human liver allografts: Expression patterns of transforming growth factor-tgfbeta1 and tgf-beta3. Transplantation. 62: 1776-1783.(1996).
[117] Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M.T., Brickey, W.J. and Ting, J.P.:Fatty acid-induced nlrp3-asc inflammasome activation interferes with insulin signaling. Nature Immunology. 12: 408-415.(2011).
[118] Lana, J.P., Martins, L.B., Oliveira, M.C., Menezes-Garcia, Z., Yamada, L.T., Vieira, L.Q., Teixeira, M.M. and Ferreira, A.V.:Tnf and il -18 cytokines may regulate liver fat storage under homeostasis conditions. Applied physiology, Nutrition, and Metabolism = Physiologie appliquee, Nutrition et Metabolisme. 41: 1295-1302.(2016).
[119] Lee, Y.H., Kim, J.H., Kim, S.H., Oh, J.Y., Seo, W.D., Kim, K.M., Jung, J.C. and Jung, Y.S.:Barley sprouts extract attenuates alcoholic fatty liver injury in mice by reducing inflammatory response. Nutrients. 8.(2016).
[120] Choi, J.S., Kim, H., Jung, M.H., Hong, S. and Song, J.:Consumption of barley beta - glucan ameliorates fatty liver and insulin resistance in mice fed a high-fat diet. Molecular Nutrition & Food Research. 54: 1004-1013.(2010).
[121] Hughes, S.A., Shewry, P.R., Gibson, G.R., McCleary, B.V. and Rastall, R.A.:In vitro fermentation of oat and barley derived beta-glucans by human faecal microbiota. FEMS Microbiology Ecology. 64: 482-493.(2008).
[122] Macfarlane, S. and Macfarlane, G.T.:Regulation of short-chain fatty acid production. The Proceedings of the Nutrition Society. 62: 67-72.(2003).
[123] Afkarian, M., Zelnick, L.R., Hall, Y.N., Heagerty, P.J., Tuttle, K., Weiss, N.S. and de Boer, I.H.:Clinical manifestations of kidney disease among us adults with diabetes, 1988-2014. JAMA. 316: 602-610.(2016).
[124] Koye, D.N., Shaw, J.E., Reid, C.M., Atkins, R.C., Reutens, A.T. and Magliano, D.J.:Incidence of chronic kidney disease among people with diabetes: A systematic review of observational studies. Diabetic Medicine : A Journal of the British Diabetic Association. 34: 887-901.(2017).
[125] Adler, A.I., Stevens, R.J., Manley, S.E., Bilous, R.W., Cull, C.A. and Holman, R.R.:Development and progression of nephropathy in type 2 diabetes: The united kingdom prospective diabetes study (ukpds 64). Kidney International. 63: 225- 232.(2003).
[126] Kume, S., Araki, S.I., Ugi, S., Morino, K., Koya, D., Nishio, Y., Haneda, M., Kashiwagi, A. and Maegawa, H.:Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014. Journal of Diabetes Investigation. 10: 1032-1040.(2019).
[127] Kimmelstiel, P. and Wilson, C.:Intercapillary lesions in the glomeruli of the kidney. The American Journal of Pathology. 12: 83-98 87.(1936).
[128] Yoshida, F., Isobe, K. and Matsuo, S.:In vivo effects of hyperglycemia on the outcome of acute mesangial injury in rats. The Journal of Laboratory and Clinical Medicine. 125: 46-55.(1995).
[129] Humphreys, B.D.:Targeting pericyte differentiation as a strategy to modulate kidney fibrosis in diabetic nephropathy. Seminars in Nephrology. 32: 463-470.(2012).
[130] Ferland-McCollough, D., Slater, S., Richard, J., Reni, C. and Mangialardi, G.:Pericytes, an overlooked player in vascular pathobiology. Pharmacology & Therapeutics. 171: 30-42.(2017).
[131] Sharma, K., McCue, P. and Dunn, S.R.:Diabetic kidney disease in the db/db mouse. American Journal of Physiology. Renal Physiology. 284: F1138-1144.(2003).
[132] Lee, S.M. and Graham, A.:Early immunopathologic events in experimental diabetic nephropathy: A study in db/db mice. Experimental and Molecular Pathology. 33: 323-332.(1980).
[133] Bivona, B.J., Park, S. and Harrison-Bernard, L.M.:Glomerular filtration rate determinations in conscious type ii diabetic mice. American Journal of Physiology. Renal Physiology. 300: F618-625.(2011).
[134] Hartono, S.P., Knudsen, B.E., Lerman, L. O., Textor, S.C. and Grande, J.P.:Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice. BMC Nephrology. 15: 58.(2014).
[135] Hempe, J., Elvert, R., Schmidts, H.L., Kramer, W. and Herling, A.W.:Appropriateness of the zucker diabetic fatty rat as a model for diabetic microvascular late complications. Laboratory Animals. 46: 32-39.(2012).
[136] Kawano, K., Hirashima, T., Mori, S. and Natori, T.:Oletf (otsuka long-evans tokushima fatty) rat: A new niddm rat strain. Diabetes Research and Clinical Practice. 24 Suppl: S317-320.(1994).
[137] Kawano, K., Mori, S., Hirashima, T., Man, Z.W. and Natori, T.:Examination of the pathogenesis of diabetic nephropathy in oletf rats. The Journal of Veterinary Medical Science. 61: 1219-1228.(1999).
[138] Lumey, L.H., Khalangot, M.D. and Vaiserman, A.M.:Association between type 2 diabetes and prenatal exposure to the ukraine famine of 1932-33: A retrospective cohort study. The Lancet. Diabetes & Endocrinology. 3: 787-794.(2015).
[139] Schmidt, I.M., Chellakooty, M., Boisen, K.A., Damgaard, I.N., Mau Kai, C., Olgaard, K. and Main, K.M.:Impaired kidney growth in low-birth-weight children: Distinct effects of maturity and weight for gestational age. Kidney International. 68: 731- 740.(2005).
[140] Aly, H., Davies, J., El-Dib, M. and Massaro, A.:Renal function is impaired in small for gestational age premature infants. The Journal of Maternal-fetal & Neonatal Medicine : The official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 26: 388-391.(2013).
[141] Ishiyama, S., Kimura, M., Umihira, N., Matsumoto, S., Takahashi, A., Nakagawa, T., Wakayama, T., Kishigami, S. and Mochizuki, K.:Consumption of barley ameliorates the diabetic steatohepatitis and reduces the high transforming growth factor beta expression in mice grown in alpha-minimum essential medium in vitro as embryos. Biochemistry and Biophysics Reports. 27: 101029.(2021).
[142] Tracy, R.E. and Ishii, T.:What is 'nephrosclerosis'? Lessons from the us, japan, and mexico. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 15: 1357- 1366.(2000).
[143] Salvatore, S.P., Cha, E.K., Rosoff, J.S. and Seshan, S.V.:Nonneoplastic renal cortical scarring at tumor nephrectomy predicts decline in kidney function. Archives of Pathology & Laboratory Medicine. 137: 531-540.(2013).
[144] Hong, S.W., Isono, M., Chen, S., Iglesias-De La Cruz, M.C., Han, D.C. and Ziyadeh, F.N.:Increased glomerular and tubular expression of transforming growth factor-beta1, its type ii receptor, and activation of the smad signaling pathway in the db/db mouse. The American Journal of Pathology. 158: 1653-1663.(2001).
[145] Rangan, G.K. and Tesch, G.H.:Quantification of renal pathology by image analysis. Nephrology (Carlton). 12: 553-558.(2007).
[146] Chen, C., Wang, C., Hu, C., Han, Y., Zhao, L., Zhu, X., Xiao, L. and Sun, L.:Normoalbuminuric diabetic kidney disease. Frontiers of Medicine. 11: 310- 318.(2017).
[147] Tsalamandris, C., Allen, T.J., Gilbert, R.E., Sinha, A., Panagiotopoulos, S., Cooper, M.E. and Jerums, G.:Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes. 43: 649-655.(1994).
[148] Yang, X.H., Pan, Y., Zhan, X.L., Zhang, B.L., Guo, L.L. and Jin, H.M.:Epigallocatechin-3-gallate attenuates renal damage by suppressing oxidative stress in diabetic db/db mice. Oxidative Medicine and Cellular Longevity. 2016: 2968462.(2016).
[149] Satirapoj, B. and Adler, S.G.:Comprehensive approach to diabetic nephropathy. Kidney Research and Clinical Practice. 33: 121-131.(2014).
[150] Shimizu, M., Furuichi, K., Toyama, T., Kitajima, S., Hara, A., Kitagawa, K., Iwata, Y., Sakai, N., Takamura, T., Yoshimura, M., Yokoyama, H., Kaneko, S. and Wada, T.:Long- term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy. Diabetes Care. 36: 3655-3662.(2013).
[151] Zhao, H.J., Wang, S., Cheng, H., Zhang, M.Z., Takahashi, T., Fogo, A.B., Breyer, M.D. and Harris, R.C.:Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. Journal of the American Society of Nephrology : JASN. 17: 2664-2669.(2006).
[152] Hudkins, K.L., Pichaiwong, W., Wietecha, T., Kowalewska, J., Banas, M.C., Spencer, M.W., Muhlfeld, A., Koelling, M., Pippin, J.W., Shankland, S.J., Askari, B., Rabaglia, M.E., Keller, M.P., Attie, A.D. and Alpers, C.E.:Btbr ob/ob mutant mice model progressive diabetic nephropathy. Journal of the American Society of Nephrology : JASN. 21: 1533-1542.(2010).
[153] Forstermann, U. and Sessa, W.C.:Nitric oxide synthases: Regulation and function. European Heart Journal. 33: 829-837, 837a-837d.(2012).
[154] Boubred, F., Daniel, L., Buffat, C., Tsimaratos, M., Oliver, C., Lelievre-Pegorier, M. and Simeoni, U.:The magnitude of nephron number reduction mediates intrauterine growth-restriction-induced long term chronic renal disease in the rat. A comparative study in two experimental models. Journal of Translational Medicine. 14: 331.(2016).
[155] Barker, D.J. and Osmond, C.:Low birth weight and hypertension. BMJ. 297: 134- 135.(1988).
[156] Painter, R.C., de Rooij, S.R., Bossuyt, P.M., Phillips, D.I., Osmond, C., Barker, D.J., Bleker, O.P. and Roseboom, T.J.:Blood pressure response to psychological stressors in adults after prenatal exposure to the dutch famine. Journal of Hypertension. 24: 1771- 1778.(2006).
[157] Chiasson, J.L., Josse, R.G., Gomis, R., Hanefeld, M., Karasik, A. and Laakso, M.:Acarbose for prevention of type 2 diabetes mellitus: The stop-niddm randomised trial. Lancet. 359: 2072-2077.(2002).
[158] Anonymous:Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: The stop-niddm trial. JAMA. 290: 486-494.(2003).
[159] Goda, T., Suruga, K., Komori, A., Kuranuki, S., Mochizuki, K., Makita, Y. and Kumazawa, T.:Effects of miglitol, an alpha-glucosidase inhibitor, on glycaemic status and histopathological changes in islets in non-obese, non-insulin-dependent diabetic goto-kakizaki rats. The British Journal of Nutrition. 98: 702-710.(2007).
[160] Fukaya, N., Mochizuki, K., Tanaka, Y., Kumazawa, T., Jiuxin, Z., Fuchigami, M. and Goda, T.:The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in oletf rats. European Journal of Pharmacology. 624: 51-57.(2009).
[161] Zhou, D., Chen, L. and Mou, X.:Acarbose ameliorates spontaneous type2 diabetes in db/db mice by inhibiting pdx1 methylation. Molecular Medicine Reports. 23.(2021).
[162] Ke, X., Walker, A., Haange, S.B., Lagkouvardos, I., Liu, Y., Schmitt-Kopplin, P., von Bergen, M., Jehmlich, N., He, X., Clavel, T. and Cheung, P.C.K.:Synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice. Molecular Metabolism. 22: 96-109.(2019).
[163] Garcia-Mazcorro, J.F., Mills, D.A., Murphy, K. and Noratto, G.:Effect of barley supplementation on the fecal microbiota, caecal biochemistry, and key biomarkers of obesity and inflammation in obese db/db mice. European Journal of Nutrition. 57: 2513-2528.(2018).
[164] Ceelen, M., van Weissenbruch, M.M., Vermeiden, J.P., van Leeuwen, F.E. and Delemarre-van de Waal, H.A.:Cardiometabolic differences in children born after in vitro fertilization: Follow-up study. The Journal of Clinical Endocrinology and Metabolism. 93: 1682-1688.(2008).
[165] Ceelen, M., van Weissenbruch, M.M., Roos, J.C., Vermeiden, J.P., van Leeuwen, F.E. and Delemarre-van de Waal, H.A.:Body composition in children and adolescents born after in vitro fertilization or spontaneous conception. The Journal of Clinical Endocrinology and Metabolism. 92: 3417-3423.(2007).
[166] Shiloh, S.R., Sheiner, E., Wainstock, T., Walfisch, A., Segal, I., Landau, D. and Harlev, A.:Long-term cardiovascular morbidity in children born following fertility treatment. The Journal of Pediatrics. 204: 84-88 e82.(2019).
[167] Meng, X.M., Nikolic-Paterson, D.J. and Lan, H.Y.:Tgf-beta: The master regulator of fibrosis. Nature Reviews. Nephrology. 12: 325-338.(2016).
[168] Koya, D., Haneda, M., Nakagawa, H., Isshiki, K., Sato, H., Maeda, S., Sugimoto, T., Yasuda, H., Kashiwagi, A., Ways, D.K., King, G.L. and Kikkawa, R.:Amelioration of accelerated diabetic mesangial expansion by treatment with a pkc beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. 14: 439- 447.(2000).
[169] Miyata, K.N., Zhao, X.P., Chang, S.Y., Liao, M.C., Lo, C.S., Chenier, I., Ethier, J., Cailhier, J.F., Lattouf, J.B., Troyanov, S., Chiasson, J.L., Ingelfinger, J.R., Chan, J.S.D. and Zhang, S.L.:Increased urinary excretion of hedgehog interacting protein (uhhip) in early diabetic kidney disease. Translational Research : The Journal of Laboratory and Clinical Medicine. 217: 1-10.(2020).
[170] Sierra-Mondragon, E., Molina-Jijon, E., Namorado-Tonix, C., Rodriguez-Munoz, R., Pedraza-Chaverri, J. and Reyes, J.L.:All-trans retinoic acid ameliorates inflammatory response mediated by tlr4/nf-kappab during initiation of diabetic nephropathy. The Journal of Nutritional Biochemistry. 60: 47-60.(2018).
[171] Eason, J.D., Gonwa, T.A., Davis, C.L., Sung, R.S., Gerber, D. and Bloom, R.D.:Proceedings of consensus conference on simultaneous liver kidney transplantation (slk). American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 8: 2243- 2251.(2008).
[172] Singal, A.K., Salameh, H., Kuo, Y.F. and Wiesner, R.H.:Evolving frequency and outcomes of simultaneous liver kidney transplants based on liver disease etiology. Transplantation. 98: 216-221.(2014).
[173] Chen, P.C., Kao, W.Y., Cheng, Y.L., Wang, Y.J., Hou, M.C., Wu, J.C. and Su, C.W.:The correlation between fatty liver disease and chronic kidney disease. Journal of the Formosan Medical Association = Taiwan yi zhi. 119: 42-50.(2020).
[174] Kitada, M., Ogura, Y. and Koya, D.:Rodent models of diabetic nephropathy: Their utility and limitations. International Journal of Nephrology and Renovascular Disease. 9: 279-290.(2016).
[175] Suriano, F., Vieira-Silva, S., Falony, G., Roumain, M., Paquot, A., Pelicaen, R., Regnier, M., Delzenne, N.M., Raes, J., Muccioli, G.G., Van Hul, M. and Cani, P.D.:Novel insights into the genetically obese ( ob/ob) and diabetic (db/db) mice: Two sides of the same coin. Microbiome. 9: 147.(2021).
[176] Hayashi, K., Kanda, T., Homma, K., Tokuyama, H., Okubo, K., Takamatsu, I., Tatematsu, S., Kumagai, H. and Saruta, T.:Altered renal microvascular response in zucker obese rats. Metabolism: Clinical and Experimental. 51: 1553-1561.(2002).
[177] Hoffmann, A., Ebert, T., Kloting, N., Kolb, M., Gericke, M., Jeromin, F., Jessnitzer, B., Lossner, U., Burkhardt, R., Stumvoll, M., Fasshauer, M. and Kralisch, S.:Leptin decreases circulating inflammatory il-6 and mcp-1 in mice. Biofactors. 45: 43-48.(2019).
[178] Gyurko, R., Siqueira, C.C., Caldon, N., Gao, L., Kantarci, A. and Van Dyke, T.E.:Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in akita mice. J Immunol. 177: 7250-7256.(2006).
[179] Yang, J.Y., Woo, S.Y., Lee, M.J., Kim, H.Y., Lee, J.H., Kim, S.H. and Seo, W.D.:Lutonarin from barley seedlings inhibits the lipopolysacchride-stimulated inflammatory response of raw 264.7 macrophages by suppressing nuclear factor-kappab signaling. Molecules. 26.(2021).
[180] Zhang, X., Du, L., Zhang, J., Li, C. and Lv, X.:Hordenine protects against lipopolysaccharide-induced acute lung injury by inhibiting inflammation. Frontiers in Pharmacology. 12: 712232.(2021).
[181] Chen, M., Tian, S., Li, S., Pang, X., Sun, J., Zhu, X., Lv, F., Lu, Z. and Li, X.:Beta - glucan extracted from highland barley alleviates dextran sulfate sodium-induced ulcerative colitis in c57bl/6j mice. Molecules. 26.(2021).
[182] Zhu, C., Guan, Q., Song, C., Zhong, L., Ding, X., Zeng, H., Nie, P. and Song, L.:Regulatory effects of lactobacillus fermented black barley on intestinal microbiota of nafld rats. Food Res Int. 147: 110467.(2021).
[183] Naseri, M., Sereshki, Z.K., Ghavami, B., Zangii, B.M., Kamalinejad, M., Moghaddam,
論文の公開元へ
